Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Rheumatoid Arthritis
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

The study aims at evaluating the effect of Some Drugs on Rheumatoid Arithritis Activity.

The study aims at evaluating the effect of Some Drugs on Rheumatoid Arithritis Activity.

Tracking Information

NCT #
NCT03770923
Collaborators
Not Provided
Investigators
Principal Investigator: Sahar k Hegazy, Prof Head of Clinical Pharmacy Department Study Director: Tarek M Mostafa, Prof Clinical pharmacy Department- Tanta University Study Chair: Salwa E Abd El-Ghany, Prof Rheumatology Dept. - Tanta University Study Chair: Fedaa AK Kotkata, Msc Clinical pharmacy Department-Tanta University